Biofrontera (BFRI) Cash from Investing Activities (2021 - 2025)

Biofrontera's Cash from Investing Activities history runs 5 years deep, the most recent figure standing at $3.0 million for Q4 2025.

• On a quarterly basis, Cash from Investing Activities rose 300200.0% year-over-year to $3.0 million in Q4 2025; TTM through Dec 2025 was $3.0 million, a 560.35% increase from a year earlier, with the FY2025 full-year figure at $3.0 million, up 100033.33% from the prior year.
• Cash from Investing Activities climbed to $3.0 million in Q4 2025 per BFRI's latest filing, from $1000.0 in the prior quarter.
• Across five years, Cash from Investing Activities topped out at $3.0 million in Q4 2025 and bottomed at -$3.0 million in Q3 2022.
• The 5-year median for Cash from Investing Activities is -$1000.0 (2024), against an average of -$103200.0.
• Across the five-year window, Cash from Investing Activities tumbled 303500.0% in 2022 and soared 300200.0% in 2025, its largest moves.
• Year by year, Cash from Investing Activities stood at -$9000.0 in 2021, then slumped by 23077.78% to -$2.1 million in 2022, then soared by 103.5% to $73000.0 in 2023, then tumbled by 101.37% to -$1000.0 in 2024, then surged by 300200.0% to $3.0 million in 2025.
• Per Business Quant, the three latest BFRI Cash from Investing Activities figures stand at $3.0 million (Q4 2025), $1000.0 (Q3 2025), and -$1000.0 (Q2 2025).